Description of the population to be studied Patients with Parkinson's disease in advanced stage who undergo STN DBS. After one months since surgery, during the first programming visit, patients will be randomized in two groups receiving either L-dopa monotherapy or DAs monotherapy (either with pramipexole or ropirinole) for 2 months.